Home / Market News / $ARAY
benzinga Corporate Catalyst Impact 65/100 ● positive

Accuray Agrees To Acquire RayStation Licenses For $8M From RaySearch Laboratories

Sep 11, 2026, 3:35 PM UTC · Primary ticker $ARAY

Accuray has agreed to purchase $8 million worth of RayStation licenses from RaySearch Laboratories to advance its online adaptive radiation therapy solutions. This collaboration aims to accelerate Accuray's commercialization efforts in this specialized cancer treatment area, with both companies jointly marketing and supporting the solutions.

Accuray (ARAY) is acquiring $8 million in RayStation licenses from RaySearch Laboratories (RAYB.ST) to bolster its online adaptive radiation therapy offerings. This agreement signifies a deeper collaboration between the two companies, aiming to accelerate the commercialization and adoption of advanced cancer treatment technologies. For Accuray, this represents an investment in its product pipeline and a potential competitive advantage in the radiation therapy market, offering a short-term positive sentiment and long-term growth opportunity. RaySearch benefits from a significant license sale and an expanded partnership, reinforcing its position as a technology provider. Traders should watch for Accuray's execution on integrating these licenses and the market reception of their new solutions.

$ARAY positive Expanded collaboration, technology acquisition
$RAYB.ST positive License sale, expanded partnership
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.